ASCPT Podcast Channel
MENU  

Episodes

PSPod: Journal Submissions in the Time of COVID

On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology & Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.

PSPod
PSPod
PSPod: Journal Submissions in the Time of COVID
Loading
/

ClinPharmPod: Journal Submissions in the Time of COVID

On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology & Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.

ClinPharmPod
ClinPharmPod
ClinPharmPod: Journal Submissions in the Time of COVID
Loading
/

A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development

On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

PSPod
PSPod
A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development
Loading
/

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It’s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

PSPod
PSPod
PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck
Loading
/

Mathematical Biology Models of Parkinson’s Disease with guests Piet van der Graaf, Suruchi Bakshi, and Chao Chen

On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling & Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published in the February 2019 issue of PSP, which is available here.

PSPod
PSPod
Mathematical Biology Models of Parkinson’s Disease with guests Piet van der Graaf, Suruchi Bakshi, and Chao Chen
Loading
/
Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved.